At Sense Therapeutics, we are enhancing two critical aspects of cancer treatment using first principles:
Cancers are diseases driven by mutations. We are developing genetic sensor tools to recognize these genetic mutations in cells and induce cell death once the mutations are identified.
Effective delivery is crucial in cancer treatment. Current delivery methods often have limited efficiency, leading to severe side effects that compromise treatment outcomes. We are developing novel methods that will significantly improve drug efficacy with minimal side effects, potentially revolutionizing our fight against cancer.
Sense Therapeutics, 1 Corporate drive, South San Francisco, CA 94080